Researchers have found that semaglutide may lower the risk of Alzheimer’s disease in people with type 2 diabetes (T2D).
Popular diabetes and weight-loss drug may reduce risk of Alzheimer’s disease
- Post author:
- Post published:October 24, 2024
- Post category:uncategorized